"Clinical Deterioration" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A critical disease progression, often measured by a set of clinical parameters, which activates HOSPITAL RAPID RESPONSE TEAM.
| Descriptor ID |
D000075902
|
| MeSH Number(s) |
C23.550.291.656.350
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Clinical Deterioration".
Below are MeSH descriptors whose meaning is more specific than "Clinical Deterioration".
This graph shows the total number of publications written about "Clinical Deterioration" by people in this website by year, and whether "Clinical Deterioration" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2017 | 2 | 0 | 2 |
| 2018 | 3 | 3 | 6 |
| 2019 | 1 | 0 | 1 |
| 2020 | 10 | 9 | 19 |
| 2021 | 5 | 3 | 8 |
To return to the timeline, click here.
Below are the most recent publications written about "Clinical Deterioration" by people in Profiles.
-
Bamlanivimab + etesevimab therapy induces SARS-CoV-2 immune escape mutations and secondary clinical deterioration in COVID-19 patients with B-cell malignancies. Ann Oncol. 2021 11; 32(11):1445-1447.
-
Spontaneous Hemoptysis in a Patient With COVID-19. Chest. 2021 07; 160(1):e39-e44.
-
Hematologic parameters and biomarkers predictors of severity in Multisystem Inflammatory Syndrome in children associated with SARS-CoV-2. Andes Pediatr. 2021 Jun; 92(3):382-388.
-
Immunosuppression as a Hallmark of Critical COVID-19: Prospective Study. Cells. 2021 05 23; 10(6).
-
Early detection of hospitalized patients with COVID-19 at high risk of clinical deterioration: Utility of emergency department shock index. Am J Emerg Med. 2021 Nov; 49:76-79.
-
A predictive model of clinical deterioration among hospitalized COVID-19 patients by harnessing hospital course trajectories. J Biomed Inform. 2021 06; 118:103794.
-
Improvement in plasma D-dimer level in severe SARS-CoV-2 infection can be an indicator of fibrinolysis suppression: Case reports. Medicine (Baltimore). 2021 Apr 16; 100(15):e25255.
-
Early treatment with inhaled budesonide to prevent clinical deterioration in patients with COVID-19. Lancet Respir Med. 2021 07; 9(7):682-683.
-
Predictors of clinical deterioration in patients with suspected COVID-19 managed in a 'virtual hospital' setting: a cohort study. BMJ Open. 2021 03 23; 11(3):e045356.
-
Are Persons Treated with Antidepressants and/or Antipsychotics Possibly Better Protected against Severe COVID 19? Pharmacopsychiatry. 2021 05; 54(3):142-143.